Cargando…
Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma
The mechanisms of drug resistance in multiple myeloma (MM) are poorly understood. Here we show that CD47, an integrin-associated receptor, is significantly up-regulated in drug resistant myeloma cells in comparison with parental cells, and that high expression of CD47 detected by immunohistochemistr...
Autores principales: | Rastgoo, Nasrin, Wu, Jian, Liu, Aijun, Pourabdollah, Maryam, Atenafu, Eshetu G., Reece, Donna, Chen, Wenming, Chang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716364/ https://www.ncbi.nlm.nih.gov/pubmed/33256380 http://dx.doi.org/10.3324/haematol.2019.227579 |
Ejemplares similares
-
High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide
por: Pourabdollah, Maryam, et al.
Publicado: (2016) -
Role of CD47 in Hematological Malignancies
por: Eladl, Entsar, et al.
Publicado: (2020) -
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
por: Tremblay-LeMay, Rosemarie, et al.
Publicado: (2018) -
Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells
por: Abdi, Jahangir, et al.
Publicado: (2019) -
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis
por: Abdi, Jahangir, et al.
Publicado: (2017)